Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Guest Information
Ankang LI
Ankang LI
Positions:

Chief Strategy and Financial Officer

Company:

Brii Biosciences

Dr. Li is Chief Financial Officer at Brii Biosciences. He has more than 10 years of experience in investment banking, business development, legal transaction and biomedical research. Before joining Brii Bio, he was the CFO of Terns Biopharmaceuticals to develop and deploy financial and corporate strategies and budget. Prior to Terns, Dr. Li was the Executive Director of Healthcare Investment Banking at Goldman Sachs responsible for Asia ex-Japan investment banking and led many high-profile IPOs for biotechnology and other healthcare clients. Dr. Li also worked in MSD Asia Pacific Innovation Hub, overseeing business development and licensing transactions in the region. Before that Dr. Li worked at international law firms, Davis Polk and Ropes & Gray, advising clients on M&A and investment transactions. Earlier in his career, he conducted postdoctoral biomedical research as Salk Institute in Dr. Ronald Evans’s lab.


Ankang Li received a Juris Doctor degree from the University of Chicago Law School, a Ph.D. degree in Biomedical Sciences from Baylor College of Medicine, a Master of Science degree in Biological Sciences from the National University of Singapore, and a Bachelor of Science degree in Biochemistry from Fudan University. He is also a chartered Financial Analyst (CFA).